Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid Receptors
Top Cited Papers
- 15 January 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 281 (3) , 1030-1037
- https://doi.org/10.1016/s0022-3565(24)36714-x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamideEuropean Journal of Pharmacology, 1995
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogsPharmacology Biochemistry and Behavior, 1989
- Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrineLife Sciences, 1987
- Suitability of urethane anesthesia for physiopharmacological investigations in various systems Part 1: General considerationsCellular and Molecular Life Sciences, 1986
- New antihypertensive cannabinoidsJournal of Medicinal Chemistry, 1983
- The triple effect ineuced by Δ9-tetrahydrocannabinol on the rat blood pressureEuropean Journal of Pharmacology, 1979
- A cannabinoid with cardiovascular activity but no overt behavioral effectsCellular and Molecular Life Sciences, 1977
- ?9-Tetrahydrocannabinol: A hypotensive effect in ratsPsychopharmacology, 1973